Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    16899778 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)
Conditions: NOMID;   CAPS;   DIRA;   NLRC4-MAS;   SAVI;   Still'S-like Diseases;   Other Undifferentiated Autoinflammatory Diseases;   Candle
Intervention:
2 Completed Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)
Condition: DIRA
Intervention: Drug: Rilonacept
3 Terminated Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease
Conditions: NOMID;   CINCA Syndrome
Intervention: Drug: Canakinumab
4 Terminated
Has Results
Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
Conditions: Nervous System Malformations;   Arthropathy, Neurogenic;   Urticaria;   Papilledema
Intervention: Drug: anakinra

Study has passed its completion date and status has not been verified in more than two years.